3rd edition EMBL-IBEC Conference


24th - 26th April 2024 · PRBB, Barcelona





James Sharpe, EMBL
Xavier Trepat, IBEC
Miki Ebisuya, EMBL
Kristina Haase, EMBL
Nuria Montserrat, IBEC
Josep Samitier, IBEC
Vikas Trivedi, EMBL

3rd edition EMBL - IBEC Conference

Engineering Multicellular Systems

EMBL and IBEC aim to contribute to the discussion on challenges and opportunities in the expanding field of engineered multicellular systems.

Recent breakthroughs in stem cell biology, organ-on-chip assays, 3-D bioprinting, and cell mechanobiology have revolutionized our ability to design and assemble multicellular living systems, from organoids to embryos.

This biennial series will focus on how engineering multicellular living systems is boosting our understanding of tissue and organ function, with applications in disease modelling, drug screening, and tissue engineering.



Organoids to engineer tissues
Cell and tissue mechanics
Self-organisation of tissues
Engineering the embryo
In vitro vascular systems
Organ on chip
Modelling tissue organisation



Abstract submission: 21/01/2024 29/01/2024 at 23:59 
Notification of acceptance: 09/02/2024 13/02/2024 
Early registration: 01/03/2024
Late registration: 10/04/2024 Closed


Barcelona Biomedical Research Park (PRBB)
Carrer Dr. Aiguader, 88
08003 Barcelona


Payment before/on 01/03
Payment after 01/03

VAT included

The registration fee covers attendance to all sessions, lunches and coffee/tea breaks during the conference and conference materials

Conference cancellation policy


For any queries about the conference, including opportunities for collaborations or sponsorship, please contact with: ibeccommunications@ibecbarcelona.eu

Or fill in the contact form below and we will be in contact with you shortly:



Zaida Alvarez

Institute for Bioengineering of Catalonia, Spain

Hans Clevers

Utrecht University, Netherlands

Jamie Davies

The University of Edinburgh, UK

Mo R. Ebrahimkhani

University of Pittsburgh, USA

Arye Elfenbein

Wildtype, USA

Maneesha Inamdar

Institute for Stem Cell Science and Regenerative Medicine, India

Madeline Lancaster

MRC Laboratory of Molecular Biology, UK

Daniel Lobo

University of Maryland, USA

Christine Mummery

Leiden University, Netherlands

Ubaka Ogbogu

University of Alberta, Canada

Satoru Okuda

WPI Kanazawa University, Japan

Sergiu Pașca

WU Tsai Neurciences Institute · Stanford University, USA

Ritu Raman

Massachusetts Institute of Technology, USA

Sharad Ramanathan

Harvard University, USA

Berna Sozen

Yale University, USA

Masayo Takahashi

Riken, Japan

Alejandro Torres-Sanchez

EMBL Barcelona, Spain

Margherita Turco

Friedrich Miescher Institute for Biomedical Research, Switzerland

Sara Wickström

Max Planck Institute for Molecular Biomedicine, Germany

Marcy Zenobi-Wong

Swiss Federal Institute of Technology, Switzerland

Check the poster and flash and short presentation list:

-Poster list

-Poster abstracts

-Short presentation list

-Flash talk list


The conference includes poster sessions and contributed oral presentations where you will have the opportunity to present your work and discuss it with your colleagues.

Abstract submission deadline: 21/01/2024
Notification of acceptance: 13/02/2024



EMBL Barcelona

Scientists at EMBL Barcelona explore how tissues and organs function and develop, in health and disease.

We combine a number of themes and approaches to achieve this:

  • The development and use of 3D in vitro models, (organoids, vascular systems, and others) where the dynamic structure and function of multicellular systems is more accessible to measurement and manipulation than in vivo.
  • Quantitative approaches and computational modelling, to create more a rigorous understanding and predictions of the dynamics of multicellular systems.
  • 3D and 4D mesoscopic imaging tailored towards tissues, organs and organoids. We develop and improve these state-of-the-art technologies, as well as using them for our research.
  • An engineering and synthetic philosophy, in which building and creating new biological models is a key part of understanding and controlling them.

Using these approaches, EMBL Barcelona studies a variety of multicellular questions:

  • Organogenesis – how a complex mammalian organ (the limb bud) develops, grows and organises itself during development.
  • Scaling – how dynamic patterning processes change their relative speeds and sizes, across different tissues and species.
  • Self-organisation – how collectives of cells spontaneously break-symmetry and cooperate to organise themselves into functional tissues.
  • Vasculogenesis – how blood vessels organise themselves into networks, and how this can be harnessed for improved tissue engineering and disease modelling.
  • Vascular diseases – how genetic or infectious diseases interact with vascular system to cause pathologies, such as malaria.

Institute for Bioengineering of Catalonia (IBEC)

The Institute for Bioengineering of Catalonia (IBEC) is a leading-edge multidisciplinary research centre based in Barcelona that conducts excellent research at the frontiers of basic and life sciences linked with engineering to generate new knowledge and applications that helps to enhance health and quality of life.

IBEC create wealth by putting together biophysics, cell engineering, nanomedicine, biomaterials, tissue engineering and the applications of information technology to health.

IBEC is a non-profit-making foundation set up in 2005 by the Departments of Health and Innovation, Universities and Enterprise of the Government of Catalonia, the University of Barcelona and the Technical University of Catalonia.

At IBEC, frontier research is combined with specific transfer targets to produce new applied technologies to be used in life and health sciences. We have the versatility to generate excellent research and, at the same time, work with clinicians and industry to develop new diagnostic or treatment systems. The model envisaged by IBEC is inspired by a creative, innovative new ecosystem based on interaction between research experts in different enabling technologies (nano-bio-info-cogno) to generate new knowledge and engineering solutions in health technology.

The knowledge that exists in IBEC is placed at the service of science and society to progress in three major research programmes:

  • Bioengineering for future medicine, with the aim of developing technology that goes beyond the existing paradigm of medical care in hospital to incorporate new areas such as personalize medicine, tailoring diagnostic and therapies to the individual, optopharmacology, diagnosis and therapies based on mechanobiology and nanomedicine.
  • Bioengineering for active ageing, with the aim of developing care and technology and improve the quality of life of an increasing older population. Assisted living technologies such as mobile health solutions, including home-based devices and services for remote monitoring, consultation and diagnosis are developed.
  • Bioengineering for regenerative therapies, with the aim of developing regenerative technologies to allow the creation of implants able to bring about the regeneration of damaged tissues or organs and to develop cell therapies.